A Promising Drug for Alzheimer's Disease with William Klein, PhD, and Richard Silverman, PhD

A Promising Drug for Alzheimer's Disease with William Klein, PhD, and Richard Silverman, PhD

Author: Northwestern University Feinberg School of Medicine July 7, 2025 Duration: 19:12

An experimental drug called NU-9 was invented at Northwestern University by Richard Silverman, PhD. It has been approved for clinical trials for the treatment of ALS and found to improves neuron health in animal models of Alzheimer's disease according to a new Northwestern Medicine study published in PNAS.

This discovery is giving scientists hope that the drug could be effective in multiple neurodegenerative diseases by addressing the underlying mechanisms of these diseases. Silverman and Northwestern University Alzheimer disease expert, William Klein, PhD, discuss the potential of NU-9 in this episode.  


Tune into Breakthroughs for a direct line to the labs and minds at Northwestern University Feinberg School of Medicine. Each episode pulls back the curtain on the process of discovery, letting you hear directly from the researchers themselves as they explain the questions that keep them up at night and the moments of insight that change everything. This isn't just about announcing findings; it's about understanding the human effort behind them. You'll get a clear sense of how a single study can ripple out, influencing treatments and shifting our entire approach to wellness. The conversations in this podcast are grounded in the belief that transforming medicine starts with asking better questions. From detailed explorations of cellular mechanisms to broader discussions on public health, the content connects the dots between specialized science and its real-world impact. Listen for thoughtful dialogue that makes complex topics accessible, always pointing toward a future where health is improved for entire communities. Produced by Northwestern University Feinberg School of Medicine, this series is for anyone curious about the tangible steps science is taking right now to create a healthier tomorrow.
Author: Language: English Episodes: 100

Breakthroughs
Podcast Episodes
The Evolution of the NIH Toolbox with Richard Gershon, PhD [not-audio_url] [/not-audio_url]

Duration: 22:28
As the primary investigator of The NIH Toolbox®, Richard Gershon, PhD, has led a team of hundreds of scientists to develop and evolve state-of-the-art digital assessments of cognition, motor, sensation and emotion which…
How Mitochondria Inform Disease Discoveries with Navdeep Chandel, PhD [not-audio_url] [/not-audio_url]

Duration: 25:06
Mitochondria are widely known as cellular "powerhouses" for their role in producing energy for cells. But pioneering research from Northwestern Medicine investigators over the last 20 years has proven mitochondria are al…
Advancing Transplant Science with Daniela Ladner, MD, MPH [not-audio_url] [/not-audio_url]

Duration: 15:08
Northwestern Medicine is dedicated to improving outcomes for patients who are in need of organ transplants. Daniela Ladner, MD, MPH, is leading research that sheds light on the barriers to transplantation as the founding…
How Drinking Alcohol Impacts Aging with Lifang Hou, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 18:19
Both long-term alcohol consumption and binge drinking can speed up biological aging, according to a Northwestern Medicine study published in the journal Aging. Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Preven…
How AI Can Improve Healthcare Delivery with Mozzi Etemadi, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 22:44
Mozziyar "Mozzi" Etemadi, MD, PhD, is supporting the transformation of healthcare delivery and patient care at Northwestern Medicine by bringing engineers into direct contact with clinical providers. In this episode, he…
Rewind: A Promising Obesity Drug with Robert Kushner, MD [not-audio_url] [/not-audio_url]

Duration: 16:34
This episode was released in February 2021, and is being re-shared to offer the research behind the popular weight loss drugs Ozempic and Wegovy. Northwestern's Robert Kushner, MD, discusses the drug semaglutide, typical…